Cite
HARVARD Citation
Tanaka, T. et al. (2013). Potential Survival Benefit of Anti-Apoptosis Protein: Survivin-Derived Peptide Vaccine with and without Interferon Alpha Therapy for Patients with Advanced or Recurrent Urothelial Cancer—Results from Phase I Clinical Trials. Clinical & developmental immunology. p. . [Online].